COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,198 Articles (22,713 medRxiv, 8,485 bioRxiv)

Most recent first Previous |  Page 1321: Articles 13201-13210  | Next

Lymphocyte count is a universal predictor to the health status and outcomes of patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-regression analysis
Lai, K.-L., Hu, F.-C., Wen, F.-Y., Chen, J.-J.
10.1101/2021.08.02.21261505 — Posted: 2021-08-04
Comparative analysis of post-vaccination anti-spike IgG antibodies in old Nursing Home Residents and in middle-aged Healthcare workers
Jeulin, H., Craus, D., Labat, C., Benetos, A.
10.1101/2021.08.03.21261014 — Posted: 2021-08-04
COVID19 vaccine type and humoral immune response in patients receiving dialysis
Garcia, P., Anand, S., Han, J., Montez-Rath, M., Sun, S., Shang, T., Parsonnet, J., Chertow, G. M., Abra, G., Schiller, B.
10.1101/2021.08.02.21261516 — Posted: 2021-08-04
Estimating infection-related human mobility networks based on time series data of COVID-19 infection in Japan
Yamada, T., Shi, S.
10.1101/2021.08.02.21261486 — Posted: 2021-08-04
Hydroxychloroquine Prophylaxis against Coronavirus Disease-19: Practice Outcomes among Health-Care Workers
Bhatt, P., Patel, V., Shah, P., Parikh, K.
10.1101/2021.08.02.21260750 — Posted: 2021-08-04
Tear antibodies to SARS-CoV-2: implications for transmission
John Selva, K., Davis, S. K., Haycroft, E. R., Lee, W. S., Lopez, E., Reynaldi, A., Davenport, M. P., Kent, H. E., Juno, J. A., Chung, A. W., Kent, S. J.
10.1101/2021.08.02.21261479 — Posted: 2021-08-04
SARS-CoV-2-specific Humoral and Cell-mediated Immune Responses after Immunization with Inactivated COVID-19 Vaccine in Kidney Transplant Recipients (CVIM 1 Study)
Bruminhent, J., Sethaudom, C., Chaumdee, P., Boongird, S., Kiertiburanakul, S., Malathum, K., Nongnuch, A., Phuphuakrat, A., Jirasiritham, S., Janphram, C., Thotsiri, S., Upama, S., Assanatham, M.
10.1101/2021.08.02.21261095 — Posted: 2021-08-04
Adverse events following COVID-19 virus vaccination in Japanese young population: The first cross-sectional study conducted by a questionnaire survey after the first-time-injection
Suehiro, M., Okubo, S., Nakajima, K., Kanda, K., Hayakawa, M., Oiso, S., Kabashima, T., Fujita, H., Ando, Y., Muro, T.
10.1101/2021.07.23.21261029 — Posted: 2021-08-04
Aspergillosis and Mucormycosis in COVID-19 Patients; a Systematic Review and Meta-analysis.
Afzal, P. S., Nasir, M.
10.1101/2021.08.01.21261458 — Posted: 2021-08-04
A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination
Mohamed, S. S., Chao, G. Y. C., Isho, B., Zuo, M., Nahass, G. R., Salomon-Shulman, R. E., Blacker, G., Fazel-Zarandi, M., Rathod, B., Colwell, K., Jamal, A., Li, Z., Quinn de Launay, K., Takaoka, A., Fahim, C., Paterson, A., Li, A., Garnham-Takaoka, J., Haq, N., Barati, S., Gilbert, L., Green, K., Mozafarihashjin, M., Samaan, P., Siqueira, W. L., Mubareka, S., Ostrowski, M. A., Rini, J., Rojas, O., McGeer, A., Weissman, I. L., Caspi-Tal, M., Strauss, S., Gingras, A.-C., Gommerman, J.
10.1101/2021.08.01.21261297 — Posted: 2021-08-04 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).